Scientific Program
08:00
Registration
08:50
Conference Opening & Welcome
Dr. Sunil Gupta, Conference Chair
09:00
Session 1: Multiple Myeloma
09:00-09:30
Multiple Myeloma in Very Young - What is Different?
09:30-10:00
Relapsed Refractory Myeloma in Elderly Population
10:00-10:30
Bispecifics and CART in Myeloma - Extending the Inevitable
10:30
Coffee Break, Networking and Visit the Exhibition
11:00
Session 2: Myeloproliferative Disorders
11:00-11:30
Essential Thrombocythemia - Grey Zone ET
11:30-12:00
Polycythemia - New Lease of Life - Triple Negative Cases
12:00-12:30
Myelofibrosis - What is Coming?
12:30
Lunch Break, Networking and Visit the Exhibition
13:30
Session 3: CLL
13:30-14:00
Is Chemotherapy Completely Forgotten?
14:00-14:30
Current Guidelines and Treatment Algorithm
14:30-15:00
How Does the Horizon Look Like?
15:00
Coffee Break, Networking and Visit the Exhibition
15:30
Session 4: CML
15:30-16:00
New Insight in CML Therapy
16:00-16:30
Can the Transplant be Completely Avoided in Chronic/Accelerated Phase?
16:30-17:00
Treatment Free Remission
17:00
End of Day One
09:00
Session 5: Low Grade Lymphoma
09:00-09:30
New Insight in the Biology Low Grade Lymphoma
09:30-10:00
CART in Low Grade Lymphoma
10:00-10:30
The Era of Bispecifics
10:30
Coffee Break, Networking and Visit the Exhibition
11:00
Session 6: High Grade Lymphoma
11:00-11:30
Risk Stratification - Identify the Difficult Ones
11:30-12:00
CART in DLBCL - Which, When and With Whon?
12:00-12:30
Bispecific in DLBCL - The Correct Piece in ZIg Saw
12:30
Lunch Break, Networking and Visit the Exhibition
13:30
Session 7: Acute Lymphoblastic Leukemia
13:30-14:00
How to Tackle the Most Difficult of ALL
14:00-14:30
Beyond the Known
14:30-15:00
Immunotherapy - Are we Winning?
15:00
Coffee Break, Networking and Visit the Exhibition
15:30
Session 8: Myelodysplastic Syndrome and Acute Myeloid Leukemia
15:30-16:00
New Guidelines in AML and Management of FLT 3 Positive Patients
16:00-16:30
New Classification in MDS
16:30-17:00
Novel Therapies in MDS and AML
17:00
Conference Closing
Dr. Sunil Gupta, Conference Chair
